| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |